
Replimune Group, Inc.
USD11.12
-0.09 (-0.76%)
CEO
Sushil Patel
IPO Date
2018-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.97
Prev. Close
$11.20
Day Low
$10.97
Day High
$12.49
52W Low
$1.50
52W High
$13.24
Market Cap
$0.92B
Volume
1.85M
| 13 Apr 2026 |
| JP Morgan |
| Neutral |
| Underweight |
| downgrade |
| 13 Apr 2026 | Wedbush | Outperform | Neutral | downgrade |
| 13 Apr 2026 | Jefferies | Buy | Hold | downgrade |
| 13 Apr 2026 | HC Wainwright & Co. | Buy | Sell | downgrade |
| 13 Apr 2026 | Leerink Partners | Outperform | Market Perform | downgrade |
| 5 Feb 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 4 Feb 2026 | Wedbush | Outperform | Outperform | maintain |